Unraveling the Potential of Recombinant Parasite Proteins and cDNA.

Products

Recombinant Parasite Proteins and cDNA

Recombinant parasite proteins and cDNA are important tools in molecular biology and biotechnology that are used for studying parasitic diseases and developing vaccines and therapeutic strategies. These tools allow researchers to create and modify parasite proteins, and cDNA can be used to express these proteins in a host organism, such as bacteria or yeast.

One of the major applications of recombinant parasite proteins and cDNA is in the development of vaccines against parasitic diseases. By producing and purifying specific parasite proteins, researchers can stimulate the immune system to produce an immune response against the parasite. This can be particularly useful for parasitic diseases that are difficult to treat or have no known cure.

In addition to vaccines, recombinant parasite proteins and cDNA are also used in the development of diagnostic tests for parasitic diseases. These tests use recombinant parasite proteins or cDNA to identify the presence of the parasite in patient samples, which can aid in diagnosis and treatment.

Recombinant parasite proteins and cDNA are also valuable research tools, allowing researchers to study protein interactions, protein structure and function, and develop new treatments for parasitic diseases. By modifying and studying these proteins, researchers can gain a better understanding of the mechanisms by which parasites infect and cause disease and develop new drugs to target these mechanisms.

The use of recombinant proteins and cDNA has become increasingly prevalent in both academic research and therapeutic applications. However, successful expression of recombinant proteins in different systems depends on several factors, including codon preference, RNA secondary structure, and GC content. By optimizing these factors, expression levels can increase significantly – up to a hundred times compared to pre-optimization. Bioclone has developed a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones cloned in an E.coli expression vector. These clones are readily available for the production of recombinant proteins.

Bioclone provides a diverse selection of recombinant antigens and codon-optimized cDNA derived from various parasite sources.

cDNA and recombinant antigen

Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
Recombinant protein applications: Western Blot may be used for other applications determined by the user.
Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
Protein Activity: N/A
Protein Tag: Contains A 6x histidine tag.
Protein Formulation: Liquid
Source: Produced from E. coli